Internal Medicine, Rheumatology · Ashland, OR
NPI
1013335173
Since 2014
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
420 Williamson Way
Ashland, OR, 97520
Phone (514) 535-5523
Groups this clinician bills Medicare through
Medicare paid, 2024
$984K
100,625 services
Medicare patients, 2024
457
Average age 74
Drug cost, 2024
$2.1M
2,155 prescriptions
Company payments, 2025
$672
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yasmin R Maldonado-Stitt was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 45,200 times for 13 patients. In total Yasmin R Maldonado-Stitt billed 100,625 services in 36 codes, and Medicare paid $984K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-25.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 45,200 | 13 | $3.61 | $163K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 19,320 | 14 | $8.54 | $165K |
| J0897 Injection, denosumab, 1 mg | Office | 1,260 | 17 | $21.05 | $27K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 776 | 84 | $0.72 | $557 |
| 99214 Office E&M - Established | Office | 761 | 319 | $86.34 | $66K |
| 99213 Office E&M - Established | Office | 428 | 248 | $57.57 | $25K |
| 96372 Injection Administration | Office | 426 | 90 | $10.79 | $4,598 |
| 96365 Intravenous Infusion, Hydration | Office | 192 | 25 | $47.69 | $9,156 |
| 99204 Office E&M - New | Office | 72 | 72 | $114.91 | $8,273 |
| 99215 Office E&M - Established | Office | 33 | 29 | $105.87 | $3,494 |
| 20610 Joint Injection | Office | 20 | 16 | $47.84 | $957 |
| 99203 Office E&M - New | Office | 12 | 12 | $64.10 | $769 |
By year: 2022 $864K for 45,412 services; 2023 $937K for 62,210 services; 2024 $984K for 100,625 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yasmin R Maldonado-Stitt prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 283 prescriptions and refills. In total Yasmin R Maldonado-Stitt wrote 2,155 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 283 | 718 | 81 | $10K |
| Prednisone Generic | 250 | 474 | 103 | $2,819 |
| Hydroxychloroquine Sulfate Generic | 231 | 627 | 76 | $11K |
| Leflunomide Generic | 169 | 469 | 62 | $11K |
| Alendronate Sodium Generic | 139 | 385 | 48 | $1,717 |
| Duloxetine Hcl Generic | 111 | 289 | 33 | $2,131 |
| Allopurinol Generic | 98 | 274 | 24 | $1,583 |
| Gabapentin Generic | 76 | 196 | 28 | $1,426 |
| Leucovorin Calcium Generic | 66 | 170 | 23 | $3,347 |
| Humira(Cf) Pen Adalimumab | 51 | 62 | Under 11 | $509K |
| Meloxicam Generic | 48 | 128 | 14 | $445 |
| Mycophenolate Mofetil Generic | 39 | 107 | 17 | $7,558 |
| Folic Acid Generic | 36 | 108 | 14 | $299 |
| Cevimeline Hcl Generic | 32 | 70 | Under 11 | $6,283 |
| Sulfasalazine Generic | 30 | 85 | Under 11 | $1,406 |
Brand drugs: - claims; generic drugs: 1,852 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yasmin R Maldonado-Stitt $672 ($672 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $207.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 15 | $207 |
| Madrigal Pharmaceuticals MDGL | 1 | $135 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $93.25 |
| Amgen Inc. AMGN | 3 | $64.99 |
| Pfizer Inc. PFE | 2 | $43.79 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $26.83 |
| UCB, Inc. UCB.BR | 1 | $25.86 |
| Organon LLC OGN | 1 | $24.06 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $18.2 |
| Janssen Biotech, Inc. JNJ | 1 | $17.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.